3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
6
Rectal Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Colonic Neoplasms
5
Lymphoma, Large-Cell, Anaplastic
4
Lymphoma, Follicular
4
Immunoblastic Lymphadenopathy
4
Colorectal Neoplasms
4
Carcinoma, Renal Cell
4
Breast Neoplasms, Male
4
Sezary Syndrome
3
Pancreatic Neoplasms
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Mantle-Cell
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma
3
Esophageal Neoplasms
3
Burkitt Lymphoma
3
Adenocarcinoma Of Esophagus
3
Waldenstrom Macroglobulinemia
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Interventions
temsirolimus
1
sargramostim
1
ruxolitinib
1
rucaparib
1
pazopanib
1
olaparib
1
eltrombopag
1
cc-486
1
Surveys and Questionnaires
1
Nivolumab
1
Monatide (IMS 3015)
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Doxorubicin
1
Docetaxel
1
Diphenhydramine
1
Cytarabine
1
Cyclophosphamide
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pathologic Complete Response
×
Immunohistochemistry
×
Clear all
No trials found.